US Physical Therapy Inc
NYSE:USPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (20.7), the stock would be worth $85.02 (19% upside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 17.4 | $71.22 |
0%
|
| 3-Year Average | 20.7 | $85.02 |
+19%
|
| 5-Year Average | 18 | $73.68 |
+3%
|
| Industry Average | 21.8 | $89.45 |
+26%
|
| Country Average | 21.9 | $89.65 |
+26%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
US Physical Therapy Inc
NYSE:USPH
|
1.1B USD | 17.4 | 49.9 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
97.1B USD | 10.5 | 14.3 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 93.8 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.7B ZAR | 14.5 | 14.1 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.9B MYR | 34.4 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.7B ZAR | 9.5 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
84.7B BRL | 107.3 | 18.1 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.4B USD | 9.1 | 11 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
100.5B CNY | 24.1 | 29.8 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 43.2 | 60.8 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.8B USD | 29.7 | 31.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.1 |
| Median | 21.9 |
| 70th Percentile | 36.5 |
| Max | 3 188 432.5 |
Other Multiples
US Physical Therapy Inc
Glance View
US Physical Therapy Inc., founded in 1990 and headquartered in Houston, Texas, has crafted a unique niche within the healthcare sector, specializing in the development and operation of outpatient physical therapy clinics across the United States. The company focuses on providing physical rehabilitation services to patients suffering from medical conditions that impair their mobility or physical function. US Physical Therapy, with its extensive network, partners with licensed physical therapists who offer personalized care aimed at improving the quality of life for those recovering from injuries or surgeries. The company emphasizes a high level of clinical expertise and personalized patient care, which not only fosters recovery but also builds trust and long-term relationships with patients and practitioners alike. The company’s revenue model largely revolves around patient visits, where each patient interaction represents a billable service. This model is further supported by a combination of direct payments and reimbursements from government and private insurance plans. By strategically expanding its clinics and continuously improving operational efficiency, US Physical Therapy maximizes its capacity to serve a broad range of patients and enhances its financial performance. The company also intelligently pursues selective acquisitions to expand its footprint and increase market share. This growth strategy, combined with its core mission of delivering effective physical therapy care, positions the company as a leading player in the outpatient physical therapy industry, balancing both patient outcomes and shareholder value.